Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Troponwerke was a German pharmaceutical company based in Cologne, founded in 1898 by Gottfried Hagen. The company initially achieved international success with 'Tropon,' a high-purity protein powder derived from animal and vegetable sources used as a nutritional supplement. Over the decades, Troponwerke transitioned into a research-oriented pharmaceutical firm, becoming particularly well-known for its portfolio in psychiatry and neurology. Its most significant pharmaceutical contribution was the development and marketing of the neuroleptic drug melperone, sold under the brand name Eunerpan. The company was acquired by Bayer in 1967 and operated as a subsidiary for several decades. It was eventually fully integrated into Bayer's pharmaceutical division in the late 1990s, and its independent legal existence ceased in the early 2000s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Troponwerke.